Dose-finding, double-blind, clinical trial of recombinant human erythropoietin (Chugai) in Japanese patients with end-stage renal disease. Research Group for Clinical Assessment of rhEPO.
Suzuki
M
M
Department of Internal Medicine, Shinrakuen Hospital, Niigata.
Hirasawa
Y
Y
Hirashima
K
K
Arakawa
M
M
Odaka
M
M
Ogura
Y
Y
Yoshikawa
Y
Y
Sanaka
T
T
Shinoda
A
A
Morii
H
H
D000293:Adolescent; D000328:Adult; D000368:Aged; D000740:Anemia / Q000097:blood / Q000150:complications / Q000188:drug therapy; D001803:Blood Transfusion; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004921:Erythropoietin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D007564:Japan; D007676:Kidney Failure, Chronic / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011897:Random Allocation
D004921:Erythropoietin